Labcorp (LH) vs Molina Healthcare (MOH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Labcorp (LH) has outperformed Molina Healthcare (MOH) over the past year, gaining 11.6% versus a loss of 4.2%. Over five years, LH leads with a +33.7% price change compared with -30.4% for MOH. Labcorp is the larger company by market cap ($25.53 billion vs $10.19 billion), about 2.5 times the size, while Molina Healthcare is growing revenue faster (+11.7% vs +7.2%).
On valuation, Labcorp trades at a lower forward P/E (15.9x vs 20.0x for Molina Healthcare). Labcorp pays a dividend yielding 0.91%, while Molina Healthcare does not currently pay one. Labcorp converts more of its revenue into profit, with a net margin of 6.3% versus 1.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LH | MOH |
|---|---|---|
| Share price | $314.80 | $195.19 |
| Market cap | $25.53B | $10.19B |
| 1-day change | +0.91% | +0.19% |
| YTD return | +24.35% | +12.26% |
| 1-year return | +11.57% | -4.15% |
| 5-year return | +33.70% | -30.44% |
| P/E ratio (TTM) | 26.04 | — |
| Forward P/E | 15.89 | 20.03 |
| EPS (TTM) | $12.09 | $0.09 |
| Dividend yield | 0.91% | 0.00% |
| Annual dividend | $2.88 | $0.00 |
| Revenue (latest FY) | $13.95B | $45.43B |
| Revenue growth (YoY) | +7.25% | +11.75% |
| Net income (latest FY) | $876.50M | $472.00M |
| Gross margin | 28.76% | 13.07% |
| Operating margin | 9.92% | 1.72% |
| Net margin | 6.28% | 1.04% |
| 52-week high | $341.80 | $244.89 |
| 52-week low | $244.52 | $121.06 |
| Distance from 52-week high | -7.90% | -20.30% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +9.34% | +7.14% |
| Average volume | 737.41K | 912.95K |
| Shares outstanding | 81.10M | 52.20M |
| Employees | 71,000 | 19,000 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Labcorp is about 2.5 times larger than Molina Healthcare by market value ($25.53B vs $10.19B).
- LH has outperformed MOH by 15.7 percentage points over the past year.
- Labcorp is more profitable, keeping 6.3 cents of every revenue dollar as net income versus 1.0 cents for Molina Healthcare.
About Labcorp
LH stock →Labcorp Holdings Inc. provides laboratory services.
Health Care · Medical Specialities · 71,000 employees
About Molina Healthcare
MOH stock →Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States.
Health Care · Medical Specialities · 19,000 employees
LH vs MOH FAQ
Which is bigger, Labcorp or Molina Healthcare?
Labcorp (LH) is larger, with a market capitalization of $25.53B compared with $10.19B for Molina Healthcare (MOH).
Which stock has performed better over the past year, LH or MOH?
LH returned +11.57% over the past 12 months, compared with -4.15% for MOH (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Labcorp or Molina Healthcare?
Labcorp pays a dividend yielding 0.91%, while Molina Healthcare does not currently pay a regular dividend.
Are Labcorp and Molina Healthcare in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.